Clinical Trial Update: Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing indacaterol 150 mcg once daily with salmeterol/fluticasone propionate 50 mcg/500 mcg twice daily in COPD; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol (indacaterol)
• Salmeterol/Fluticasone Propionate

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-04-28